PB

Professor Bennett

Regis Healthcare Limited | Non-Executive Director
Professor Bennett has over 40 years of healthcare industry experience across the private, public and not-for-profit sectors. She is an experienced nonexecutive director in forprofit and social enterprises, Patron of Research Australia, Convenor of the Champions of Change Health Coalition STEM and Health Group for gender equality, and a member of Chief Executive Women. She is also an advisor to the Digital Health Cooperative Research Centre and in 2024 completed a certificate on AI Ethics and Board Oversight. Her previous Board nonexecutive director roles include Telstra Health, HeartWare Limited, Symbion Health Limited and Chair of Sydney Childrens Hospital Network. In December 2021, she retired from and was awarded Emeritus Professor by The University of Notre Dame Australia where she was Deputy Vice Chancellor, Enterprise & Partnerships and Dean, School of Medicine, Sydney for over ten years. Her prior experience has included being Group Executive and Chief Medical Officer for MBF and then Bupa Health and Care Services; CEO and later Chair of Research Australia; Managing Director of Total Health Enterprise Ltd; Partner in Health and Life Sciences for KPMG Australia; CEO of Westmead Hospital and Community Health Services; General Manager for the Royal Hospital for Women; and Head of Planning in NSW Health. She has an active commitment to and involvement in medical professional issues, public policy and medical research. In 2008 she was appointed as Chair of the National Health and Hospitals Reform Commission producing a longterm blueprint for reform of health and aged care in Australia. She was awarded an Officer of the Order of Australia (AO) in the 2014 Australia Day Honours in recognition of her distinguished service to medicine and health care leadership. She is a member of the Risk Management Committee.

Companies and Roles

Company
Title
Tenure
Since
REG
Regis Healthcare Limited
  • Non-Executive Director
8yrs, 4mthMar 2018
SHL
Sonic Healthcare Limited
  • Non-Executive Director
3yrs, 9mthSep 2022

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
SHL
Sonic Healthcare Limited
01/10/2508,200N/AN/A
REG
Regis Healthcare Limited
25/08/2582,500N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
SHL
Sonic Healthcare Limited
01/10/25
Buy
1,100$21.510$23,661On-market trade
SHL
Sonic Healthcare Limited
09/04/25
Buy
1,000$25.000$25,000On-market trade
SHL
Sonic Healthcare Limited
11/12/24
Buy
1,000$28.483$28,483On-market trade
SHL
Sonic Healthcare Limited
29/05/24
Buy
1,000$24.010$24,010On-market trade
SHL
Sonic Healthcare Limited
19/04/24
Transfer
2,000$27.290$54,580Off-market transfer